Wockhardt's Zaynich Proves Effective in Treating US Pediatric Cancer Patient

Unknown Apr 02, 2026 3 Views

Wockhardt Limited has announced another significant success with its investigational antibiotic, Zaynich, in treating a pediatric cancer patient in the United States. The patient, who was suffering from a severe infection caused by extreme-drug-resistant bacteria, was successfully treated with Za...

Stay Ahead – Explore Now! US Greenlights Patriot Missile Delivery To Ukraine Amid Rising Tensions